Iodine-125 Brachytherapy Prophylaxis after Radiofrequency Ablation Cannot Benefit Patients in High Risk of Locoregional Hepatocellular Carcinoma Recurrence

This study evaluated if iodine-125 brachytherapy prophylaxis after radiofrequency ablation (RFA) prolongs time to recurrence (TTR) and overall survival (OS) of patients in high risk of locoregional hepatocellular carcinoma (HCC) recurrence. 116 patients with total tumor necrosis after RFA were divid...

Volledige beschrijving

Bewaard in:
Bibliografische gegevens
Gepubliceerd in:Sci Rep
Hoofdauteurs: Tu, Jian-Fei, Ding, Ya-Hui, Chen, Li, Ying, Xi-Hui, Zhang, Deng-Ke, Wu, Fa-Zong, Zhao, Zhong-Wei, Ji, Jian-Song, Zhang, Wang-Gang, Zou, Hai
Formaat: Artigo
Taal:Inglês
Gepubliceerd in: Nature Publishing Group UK 2017
Onderwerpen:
Article
Online toegang:https://ncbi.nlm.nih.gov/pmc/articles/PMC5473839/
https://ncbi.nlm.nih.gov/pubmed/28623296
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/s41598-017-03831-5
Tags: Voeg label toe
Geen labels, Wees de eerste die dit record labelt!

Gelijkaardige items